|
|
Medtronic Plc's Yearly Operating Income Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Operating Income Annual Growth Rates Y/Y▼
|
Annual Operating Income Annual Growth Rates Y/Y▼
|
MDT Annual Operating Income Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Operating Income Change |
-4.64 % |
28.28 % |
-6.41 % |
-23.56 % |
-5.76 % |
Annual Operating Income (in millions $) |
$5,485.00 |
$5,752.00 |
$4,484.00 |
$4,791.00 |
$6,268.00 |
Annual Operating Income Growth
Comment |
Medtronic Plc experienced detoriation of Annual Operating Income for the fiscal year ended 2023 by -4.64% to $ 5,485.00 millions, compare to $ 5,752.00 in Annual Operating Income reported in the previous year. The decline in company's annual Operating Income accelerated, from the 28.28 % gain, in the fiscal year ended 2022.
Medtronic Plc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Operating Income within Healthcare Sector | Y/Y Operating Income Growth % | 2023 Annual Operating Income | Johnson and Johnson | -44.17 % | $ 21,207.000 millions | Abbvie inc | -29.59 % | $ 12,757.000 millions | Novartis Ag | 6.22 % | $ 9,769.000 millions | Eli Lilly And Company | 43.92 % | $ 10,257.700 millions | Biogen Inc | -47.44 % | $ 1,831.100 millions | Tenet Healthcare Corp | 7.59 % | $ 2,510.000 millions | Becton Dickinson And Company | -7.49 % | $ 2,111.000 millions | Organon and Co | -38.41 % | $ 1,257.000 millions | Iqvia Holdings Inc | 9.89 % | $ 1,977.000 millions | Edwards Lifesciences Corporation | -12.26 % | $ 1,534.100 millions | Fresenius Medical Care Ag | -9.41 % | $ 1,533.771 millions | Encompass Health Corporation | 12.91 % | $ 1,870.900 millions | Boston Scientific Corporation | 42.09 % | $ 2,343.000 millions | Hologic Inc | -59.25 % | $ 668.400 millions | Agilent Technologies inc | -16.56 % | $ 1,350.000 millions | Viatris Inc | -52.55 % | $ 766.200 millions | Intuitive Surgical Inc | 12.03 % | $ 1,766.800 millions | Mettler toledo International Inc | -3.42 % | $ 1,449.804 millions | Quest Diagnostics Inc | -11.62 % | $ 1,262.000 millions | Davita Inc | 19.69 % | $ 1,602.784 millions | Avantor Inc | -38.38 % | $ 696.400 millions | Resmed Inc | 13.15 % | $ 1,131.871 millions | United Therapeutics Corporation | 20.95 % | $ 1,184.900 millions | Idexx Laboratories Inc | 22.07 % | $ 1,097.128 millions | Vir Biotechnology Inc | | | |